Amoxicillin Trihydrate, Clavulanate Potassium

Verify with FDA CVM →

169 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
169
Total Reports
15
Deaths Reported
890.0%
Death Rate

Active Ingredients

Amoxicillin Trihydrate, Clavulanate Potassium

Administration Routes

OralUnknownOther

Species Affected

Dog 120
Cat 29
Unknown 20

Most Affected Breeds

Unknown 20
Dog (unknown) 16
Retriever - Labrador 16
Domestic Longhair 8
Domestic Shorthair 8
Beagle 7
Cat (unknown) 6
Bulldog - French 5
Crossbred Canine/dog 5
Shepherd Dog - German 4

Most Reported Reactions

Vomiting 36
Lack of efficacy - NOS 15
Lethargy (see also Central nervous system depression in 'Neurological') 15
Diarrhoea 11
Unable to stand 9
Limb weakness 8
Death by euthanasia 7
Death 7
Seizure NOS 7
Underdose 7
Polydipsia 6
Elevated alanine aminotransferase (ALT) 6

Outcome Breakdown

Outcome Unknown
78 (52.3%)
Recovered/Normal
53 (35.6%)
Died
8 (5.4%)
Euthanized
7 (4.7%)
Ongoing
3 (2.0%)

Data Summary

Metric Value
Total adverse event reports 169
Reports involving death 15
Case-fatality rate (reported events) 890.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Amoxicillin Trihydrate, Clavulanate Potassium Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 169 adverse event reports referencing Amoxicillin Trihydrate, Clavulanate Potassium, including 15 reports in which the animal died — a 890.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Amoxicillin Trihydrate, Clavulanate Potassium. Reported administration routes include Oral, Unknown, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Amoxicillin Trihydrate, Clavulanate Potassium reports are Dog (120 reports), Cat (29 reports), Unknown (20 reports), with Dog accounting for the largest share. Within those species, Unknown (20), Dog (unknown) (16), Retriever - Labrador (16) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Amoxicillin Trihydrate, Clavulanate Potassium are Vomiting (36), Lack of efficacy - NOS (15), Lethargy (see also Central nervous system depression in 'Neurological') (15), Diarrhoea (11). Of the 149 reports with a coded outcome, Outcome Unknown is the leading category at 52.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Amoxicillin Trihydrate, Clavulanate Potassium.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial